Physician profile
Michael Miller
NPI 1891770665
$5,883.59
in general payments reported to CMS, 2019-2025
35 companies · $2,165 in 2025
The $2,165 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $75.84 · 2021: $130 · 2022: $636 · 2023: $694 · 2024: $1,998 · 2025: $2,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,857.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $903.40 | 2021-2025 | |
| Novo Nordisk INC | $696.30 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $579.03 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $516.05 | 2022-2025 | |
| Lilly USA, LLC | $465.77 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Exact Sciences Corporation | $294.14 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $248.84 | 2023-2025 | Veozah |
| Tris Pharma INC | $234.80 | 2025 | Dyanavel Xr, Quillivant, Quillichew Er |
| Abbott Laboratories | $230.04 | 2022-2024 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $222.39 | 2024-2025 | Voquezna |
| Amgen INC. | $186.08 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.77 | 2022-2025 | Jardiance, Ofev |
| Glaxosmithkline, LLC. | $133.95 | 2019-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Boston Scientific Corporation | $107.58 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $104.35 | 2024-2025 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.